دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Recognizing racial and ethnic disparities in women’s reproductive health is not enough
Samantha Butts, M.D., M.S.C.E. a and Anuja Dokras, M.D., M.H.C.I., Ph.D a,b
doi : 10.1016/j.fertnstert.2023.01.045
Volume 119, Issue 3, March 2023, Pages 339-340
Racial and ethnic disparities in assisted reproductive technology: a systematic review
Jamie M. Merkison, M.D., Anisha R. Chada, M.D., Audrey M. Marsidi, M.D., and Jessica B. Spencer, M.D., M.Sc.
doi : 10.1016/j.fertnstert.2023.01.023
Volume 119, Issue 3, March 2023, Pages 341-347
Racial and ethnic disparities in polycystic ovary syndrome
Katherine VanHise, M.D., a Erica T. Wang, M.D., M.A.S., a Keith Norris, M.D., Ph.D., b Ricardo Azziz, M.D., M.P.H., M.B.A., c,d,e,f Margareta D. Pisarska, M.D., a and Jessica L. Chan, M.D., M.S.C.E.
doi : 10.1016/j.fertnstert.2023.01.031
Volume 119, Issue 3, March 2023, Pages 348-354
Racial disparities in uterine fibroids and endometriosis: a systematic review and application of social, structural, and political context
Jodie G. Katon, PhD, MS, a Torie C. Plowden, MD, MPH, b and Erica E. Marsh, MD, MSCIc
doi : 10.1016/j.fertnstert.2023.01.022
Volume 119, Issue 3, March 2023, Pages 355-363
Racial and ethnic disparities in women’s mental health: a narrative synthesis of systematic reviews and meta-analyses of the US-based samples
Phoutdavone Phimphasone-Brady, Ph.D., a,b Chloe E. Page, Ph.D.,a Diab A. Ali, M.D., a Heinrich C. Haller, B.A., a and Korrina A. Duffy, Ph.D.
doi : 10.1016/j.fertnstert.2023.01.032
Volume 119, Issue 3, March 2023, Pages 364-374
Blind physicians and the elephant: “Reality is one, although wise physicians speak of it variously�
Victoria Fitz, M.D. a Bala Bhagavath, M.D. b Steven R. Lindheim, M.D., M.M.M.c,d,e John Petrozza, M.D
doi : 10.1016/j.fertnstert.2022.12.031
Volume 119, Issue 3, March 2023, Pages 375-376
Surgical approach to 4 different reproductive pathologies by 3 different gynecologic subspecialties: more similarities or differences?
John C. Petrozza, M.D., a Victoria Fitz, M.D., a Bala Bhagavath, M.D., b Jose Carugno, M.D., c Jaclyn Kwal, M.D., c Emad Mikhail, M.D., d Moawad Nash, M.D., e Syem K. Barakzai, M.D., f Dario R. Roque, M.D., g Amy J. Bregar, M.D., f Joseph Findley, M.D., h Michael Neblett, M.D., i Rebecca Flyckt, M.D., h Zaraq Khan, M.B.B.S., M.S., i and Steven R. Lindheim, M.D., M.M.M. j,k,l
doi : 10.1016/j.fertnstert.2022.12.032
Volume 119, Issue 3, March 2023, Pages 377-389
A “first� on the horizon: the expansion of uterus transplantation to transgender women
Elliott G. Richards, M.D., Ph.D.a Cecile A. Ferrando, M.D. a Ruth M. Farrell, M.D. a Rebecca L. Flyckt, M.D.
doi : 10.1016/j.fertnstert.2023.01.017
Volume 119, Issue 3, March 2023, Pages 390-391
COVID-19 vaccination and changes in the menstrual cycle among vaccinated persons
Leslie V. Farland, Sc.D., a,b,c Sana M. Khan, M.P.H., a Alexandra Shilen, M.P.H., a Kelly M. Heslin, M.P.H., a Providence Ishimwe, M.P.H,a Alicia M. Allen, Ph.D.,a,d Melissa M. Herbst-Kralovetz, Ph.D., c,e,f Nichole D. Mahnert, M.D., f Kristen Pogreba-Brown, Ph.D., a Kacey C. Ernst, Ph.D., a and Elizabeth T. Jacobs, Ph.D. a,
doi : 10.1016/j.fertnstert.2022.12.023
Volume 119, Issue 3, March 2023, Pages 392-400
Perioperative opioid prescribing after male fertility procedures is associated with new persistent opioid use: retrospective analysis of a large claims database
Corey A. Able, B.S., a Andrew T. Gabrielson, M.D., b Chris Meilchen, B.S., a Jaden R. Kohn, M.D., M.P.H., c and Taylor P. Kohn, M.D., M.Phil. B
doi : 10.1016/j.fertnstert.2022.12.015
Volume 119, Issue 3, March 2023, Pages 401-408
Opioid use after male fertility procedures: Is it time to rethink prescribing patterns?
Sirpi Nackeeran, M.D., M.P.H.
doi : 10.1016/j.fertnstert.2022.12.044
Volume 119, Issue 3, March 2023, Page 409
Sperm human papillomavirus infection and risk of idiopathic recurrent pregnancy loss: insights from a multicenter case–control study
Andrea Busnelli, Ph.D., a,b Andrea Garolla, Ph.D., c Chiara Tersigni, Ph.D., d Vittorio Parodi, M.D., a Annalisa Inversetti, M.D., a,b Paolo Emanuele Levi-Setti, M.D., a,b Giovanni Scambia, M.D., d,e and Nicoletta Di Simone, Ph.D. a,b
doi : 10.1016/j.fertnstert.2022.12.002
Volume 119, Issue 3, March 2023, Pages 410-418
Are sperm human papilloma virus infections a missing link for idiopathic recurrent pregnancy loss?
Richard J. Fantus, M.D. a Ajay K. Nangia, M.D. a Joshua A. Halpern, M.D.
doi : 10.1016/j.fertnstert.2023.01.002
Volume 119, Issue 3, March 2023, Page 419
Whole genome bisulfite sequencing of sperm reveals differentially methylated regions in male partners of idiopathic recurrent pregnancy loss cases
Delna Irani, M.Sc., a Nafisa Balasinor, Ph.D., a Vandana Bansal, M.D., b Deepti Tandon, M.D., c Anushree Patil, M.D., c and Dipty Singh, Ph.D. a
doi : 10.1016/j.fertnstert.2022.12.017
Volume 119, Issue 3, March 2023, Pages 420-432
Uterine niche is associated with adverse in vitro fertilization and intracytoplasmic sperm injection outcomes: a retrospective cohort study
Wen Yao, M.D., Ying Chen, M.D., Haixia Yao, M.M., Qingyun Yao, M.D., Lan Wang, M.D., Meng Wang, M.D., and Jing Yue, M.D.
doi : 10.1016/j.fertnstert.2022.12.001
Volume 119, Issue 3, March 2023, Pages 433-441
We created uterine imperfection, but when do we need to fix it?
Arti Taggar, M.D., M.P.H. Daniel Grow, M.D., M.H.C.M.
doi : 10.1016/j.fertnstert.2023.01.006
Volume 119, Issue 3, March 2023, Pages 442-443
Antimüllerian hormone is not associated with embryo ploidy in patients with and without infertility undergoing in vitro fertilization with preimplantation genetic testing
Yael R. Stovezky, B.A., a Phillip A. Romanski, M.D., M, Sc, b Pietro Bortoletto, M.D., M.Sc., b and Steven D. Spandorfer, M.D.
doi : 10.1016/j.fertnstert.2022.11.018
Volume 119, Issue 3, March 2023, Pages 444-453
A nail in the coffin: the antimüllerian hormone “quality or quantity� debate
Bradley S. Hurst, M.D.
doi : 10.1016/j.fertnstert.2023.01.009
Volume 119, Issue 3, March 2023, Page 454
Early noninvasive diagnosis of endometriosis: dysmenorrhea and specific ultrasound findings are important indicators in young women
Francesco Giuseppe Martire, M.D., a Consuelo Russo, M.D., a Aikaterini Selntigia, M.D., a Elvira Nocita, M.D., a Giorgia Soreca, M.D., a Lucia Lazzeri, M.D., Ph.D., b Errico Zupi, M.D., b and Caterina Exacoustos, M.D., Ph.D. a
doi : 10.1016/j.fertnstert.2022.12.004
Volume 119, Issue 3, March 2023, Pages 455-464
Disease-free survival does not differ according to fertility preservation technique for young women with breast cancer
Charlotte Sonigo, M.D., Ph.D., a,b Noemi Amsellem, M.D., a Anne Mayeur, M.D., c Laetitia Laup, M.D., d Barbara Pistilli, M.D., e Suzette Delaloge, M.D., Ph.D., e Florence Eustache, M.D., Ph.D., f Christophe Sifer, M.D., f Sophia Rakrouki, M.S.,d Alexandra Benoit, Ph.D., a Maeliss Peigne, M.D., Ph.D., d and Michael Grynberg, M.D., Ph.D. a,d
doi : 10.1016/j.fertnstert.2022.11.020
Volume 119, Issue 3, March 2023, Pages 465-473
Fertility preservation in breast cancer: more good news!
Mary Ellen Pavone, M.D., M.S.C.I.
doi : 10.1016/j.fertnstert.2023.01.018
Volume 119, Issue 3, March 2023, Page 474
Pregnancy attempts among adolescent and young adult cancer survivors
Chelsea Anderson, Ph.D., a Victoria Fitz, M.D., b Allison Deal, M.S., c Darios Getahun, M.D., Ph.D., d Marilyn L. Kwan, Ph.D., e Jennifer E. Mersereau, M.D., f Lawrence H. Kushi, Ph.D., e Chun R. Chao, Ph.D., d and Hazel B. Nichols, Ph.D.
doi : 10.1016/j.fertnstert.2022.12.024
Volume 119, Issue 3, March 2023, Pages 475-483
Pregnancy outcomes with donor oocyte embryos in patients diagnosed with adenomyosis using the Morphological Uterus Sonographic Assessment criteria
Ebernella Shirin Dason, M.D., a,b Madalina Maxim, H.B.Sc., c Alexander Hartman, M.D., d Qixuan Li, M.Sc., e Salina Kanji, M.D., a,b Tiantian Li, Ph.D., f Charis Ng, M.D., g Ella Huszti, Ph.D., e Mara Sobel, M.D., M.Sc., a,b and Crystal Chan, M.D., M.Sc. a,f
doi : 10.1016/j.fertnstert.2022.12.021
Volume 119, Issue 3, March 2023, Pages 484-489
Sonographic diagnosis of adenomyosis—ultrasound that cried wolf?
Ido Feferkorn, M.D. a Togas Tulandi, M.D., M.H.C.M.
doi : 10.1016/j.fertnstert.2022.12.043
Volume 119, Issue 3, March 2023, Pages 490-491
Single-cell profiling of the microenvironment in decidual tissue from women with missed abortions
Ren Hou, M.D, Ph.D., a,b Renliang Huang, M.M., a Yanling Zhou, M.M., b Dan Lin, B.S., a Jing Xu, M.M., a Liuqing Yang, B.S., a Xiaolan Wei, M.M., c Zhuoming Xie, M.S., c and Qiaomiao Zhou, M.M.
doi : 10.1016/j.fertnstert.2022.12.016
Volume 119, Issue 3, March 2023, Pages 492-503
Surgical removal of FIGO type 0 and 1 fibroids ameliorates the expression of endometrial proinflammatory transcription factors and receptivity modulators
Nur Dokuzeyl€ul G€ung€or, M.D., a Murat €Onal, M.D., b Asena Ayar Madenli, M.D., c and Mehmet Agar, M.D.
doi : 10.1016/j.fertnstert.2022.11.021
Volume 119, Issue 3, March 2023, Pages 504-513
Two studies in the same center, on the same patient population and topic, but with different results: Is the experimental design to blame?
Carlos Simon, M.D., Ph.D. a,b,c Maria Ruiz-Alonso, M.Sc.d Carlos Gomez, M.Sc.d Diana Valbuena, M.D., Ph.D.
doi : 10.1016/j.fertnstert.2022.11.019
Volume 119, Issue 3, March 2023, Pages 514-515
Reply of the Authors: Not in the same patient population but on the same topic. The endometrial receptivity array test has not proven clinically useful to improve implantation yet, and our data support this fact
Mauro Cozzolino, M.D. a,b,c Patricia Diaz-Gimeno, Ph.D.b Antonio Pellicer, M.D., Ph.D.a,b Nicolas Garrido, M.Sc., Ph.D.
doi : 10.1016/j.fertnstert.2022.12.029
Volume 119, Issue 3, March 2023, Pages 516-517
Retraction notice to "Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial"
doi : 10.1016/j.fertnstert.2023.02.001
Volume 119, Issue 3, March 2023, Page 518
